<div id="readability-page-1"><div><p><span>Evnin Luke B Chairman of the Board of Werewolf Therapeutics Inc [HOWL] filed a Form 4 on November 20, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><td><span>Date</span></td><td><span>11/18/25-11/20/25</span></td></tr><tr><td><span>Transaction</span></td><td><span>Planned Sale(1)</span></td></tr><tr><td><span>Shares</span></td><td><span>102,753</span></td></tr><tr><td><span>Price</span></td><td><span>$0.92</span></td></tr><tr><td><span>Value</span></td><td><span>$94,933</span></td></tr></tbody></table></div><p><span>Ending Holdings: 3,413,127 - Indirect</span></p><ul><li><span>(1)</span></li><li><span>Executed pursuant to a prearranged trading plan (10b5-1).</span></li></ul><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

HOWL

<p>Evnin Luke B, Chairman of Werewolf Therapeutics Inc, sold 102,753 shares worth $94,933 as part of a prearranged trading plan (10b5-1) between November 18-20, 2025. His ending holdings are 3,413,127 shares indirectly. The transaction was disclosed in a Form 4 filed with the SEC.</p>

Chmn Evnin Sells 102,753 ($94.9K) Of Werewolf Therapeutics Inc [HOWL]